Dr Wises Formula II Intestinal Calm
- Manufacturer
- Apotheca Company
- Effective date
- 2022-04-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:03:17
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Lycopodium clavatum 12X, Pulsatilla 12X.
OTC - PURPOSE SECTION
INDICATIONS: For temporary relief of symptoms associated with constipation, bloating, diarrhea and other symptoms of poor digestion.
WARNINGS SECTION
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Consult a physician for use in children under 12 years of age.
If you have an allergy to fish (including Salmon), you should not use this product.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Adults take 6 capsules one time daily. Children under 30 lbs take 3 capsules one time daily, up to 60 lbs take 3 capsules one time daily, up to 90 lbs take 4 capsules one time daily. Can take capsule apart and mix powder in juice.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Aronia (Berry), Gelatin, DNA (Deoxyribonucleic acid)*, Folic acid, L-carnosine, Rice flour, RNA (Ribonucleic acid), Vitamin D3 (from Cholecalciferol).
* Contains Salmon
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
INDICATIONS: For temporary relief of symptoms associated with constipation, bloating, diarrhea and other symptoms of poor digestion.
OTC - QUESTIONS SECTION
Dist. By:
J and L Health LLC
6572 E. 24th Street
Tulsa, OK 74129
918-836-0565
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
J and L HEALTH
Dr. Wise's Formula II Intestinal Calm
Homeopathic
180 Capsules
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0176-1 | 2022-04-19 | C162847 | 48780-1 | 9d75b9cf-ffbf-f424-e053-dadaa90a57ce | Dr. Wise's Formula II Intestinal Calm |
| 57520-0176-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-ffbf-f424-e053-dadaa90a57ce | Dr. Wise's Formula II Intestinal Calm |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 1 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 1 | |
| ARONIA MELANOCARPA FRUIT | INACTIVE INGREDIENT | S935718Z2Q | 1 | |
| CARNOSINE | INACTIVE INGREDIENT | 8HO6PVN24W | 1 | |
| CHOLECALCIFEROL | INACTIVE INGREDIENT | 1C6V77QF41 | 1 | |
| FOLIC ACID | INACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | 1 | |
| HERRING SPERM DNA | INACTIVE INGREDIENT | 51FI676N6F | 1 | |
| RICE | INACTIVE INGREDIENT | 659G217HPG | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | INACTIVE INGREDIENT | J17GBZ5VGX | 1 |
Products#
Every source-derived product name is available through these pages.
- Dr Wises Formula II Intestinal Calm
- Lycopodium clavatum, Pulsatilla,
- LYCOPODIUM CLAVATUM SPORE
- PULSATILLA VULGARIS
- CARNOSINE
- CHOLECALCIFEROL
- FOLIC ACID
- BROWN RICE
- GELATIN
- ARONIA MELANOCARPA FRUIT
- SACCHAROMYCES CEREVISIAE RNA
- HERRING SPERM DNA
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0176 | 57520-0176-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LYCOPODIUM CLAVATUM SPORE | C88X29Y479 | ACTIB |
| PULSATILLA VULGARIS | I76KB35JEV | ACTIB |
| CARNOSINE | 8HO6PVN24W | IACT |
| CHOLECALCIFEROL | 1C6V77QF41 | IACT |
| FOLIC ACID | 935E97BOY8 | IACT |
| BROWN RICE | 659G217HPG | IACT |
| GELATIN | 2G86QN327L | IACT |
| ARONIA MELANOCARPA FRUIT | S935718Z2Q | IACT |
| SACCHAROMYCES CEREVISIAE RNA | J17GBZ5VGX | IACT |
| HERRING SPERM DNA | 51FI676N6F | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GELATIN | GELATIN | 2G86QN327L | TABLET / ORAL | 46 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE / ORAL | 10932 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 14 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, COATED PELLETS / ORAL | 65 mg | ||
| GELATIN | GELATIN | 2G86QN327L | DROPS / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION / INTRAMUSCULAR | 16 %w/v | ||
| GELATIN | GELATIN | 2G86QN327L | ELIXIR / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | SYRUP / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | SOLUTION / INTRAVENOUS | 34.8 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET / SUBLINGUAL | 19 mg | ||
| GELATIN | GELATIN | 2G86QN327L | PASTE / DENTAL | 252 mg | ||
| GELATIN | GELATIN | 2G86QN327L | POWDER / ORAL | 100 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / ORAL | 120 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, EXTENDED RELEASE / ORAL | 239 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 14 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, SUGAR COATED / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| GELATIN | GELATIN | 2G86QN327L | PASTILLE / ORAL | 143 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 14 mg | ||
| GELATIN | GELATIN | 2G86QN327L | SYSTEM / TOPICAL | 1050 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, CHEWABLE / ORAL | 24 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION / INTRACAVITARY | 0.05 ml | ||
| GELATIN | GELATIN | 2G86QN327L | SUPPOSITORY / VAGINAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, COATED / ORAL | 288 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET / PERIODONTAL | 3.44 mg | ||
| GELATIN | GELATIN | 2G86QN327L | GUM, CHEWING / BUCCAL | 102 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, EXTENDED RELEASE / ORAL | 1229 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, SUSPENSION / INTRAMUSCULAR | 1.3 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, DELAYED RELEASE / ORAL | 19 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 2 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, FILM COATED / ORAL | 57 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, LIQUID FILLED / ORAL | 1042 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, DELAYED RELEASE / ORAL | 1791 mg | ||
| GELATIN | GELATIN | 2G86QN327L | POWDER / RESPIRATORY (INHALATION) | 100 mg | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, COATED / ORAL | 42.12 mg | ||
| GELATIN | GELATIN | 2G86QN327L | POWDER, FOR SUSPENSION / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | WAFER / ORAL | NA | ||
| GELATIN | GELATIN | 2G86QN327L | SOLUTION / ORAL | 34.8 mg | ||
| GELATIN | GELATIN | 2G86QN327L | DROPS / NASAL | 50 mg/1ml | ||
| GELATIN | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | 13 mg | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION / SUBCUTANEOUS | 16 %w/v | ||
| GELATIN | GELATIN | 2G86QN327L | INJECTION / INTRAVENOUS | 20 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 558faa29-2161-4c05-95b2-8ab7d6c5d1bd | 9ab34b8b-9173-4c40-bb49-c9b096200c40 | 2022-04-19 | Warnings | 558faa29-2161-4c05-95b2-8ab7d6c5d1bd 9ab34b8b-9173-4c40-bb49-c9b096200c40 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
